![[ Visit Client Website ]](images/banner.gif)
Learning Objectives
At the conclusion of this presentation attendees will be able to:
- Know how to inform the FDA
- Explain how the Family Smoking Prevention & Tobacco Control Act affects state and local tobacco control
- New methods for engaging FDA and federal tobacco control
Key Points: FDA law and how it could better advance state and local tobacco control
Educational Experience: Strategies for how state and lcoal groups can interact with FDA and methods for common action
Benefits: Enhancing state and local involvement to best serve FDA law and public health
Traditionally, tobacco control has been led by state and local programs that have made historic progress in curbing tobacco use over the last 25 years. In 2009, the Family Smoking Prevention and Tobacco Control Act was signed into law and allowed FDA to regulate tobacco products and expanded state and local authority for tobacco marketing. By its nature, FDA is a regulatory body that maintains neutrality in its science decision making which may limit input and influence from state and local tobacco control programs. In the past, other local public health movements have informed and in the case of AIDs “reformed” the FDA. In contrast, the risk of the tobacco “industry” capture of the FDA process is very real given their expert knowledge of tobacco products. Strategies for how state and local groups can better interact with FDA will be described as well as methods for common action among local groups to best serve the FDA law and public health.